Reviva Pharmaceuticals Holdings, Inc. (RVPH) — 分析师展望 / 分析师共识目标价为. 基于 8 位分析师评级, 共识为 看涨 — 6 买入, 2 持有.
分析师预估 每股收益(EPS)为 $-19.71 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.90 vs 预期 $-19.71 (超预期 +95.4%). 2025: 实际 $-5.48 vs 预期 $-6.34 (超预期 +13.5%). 分析师准确度: 0%.
RVPH 分析师评级
Buy
基于过去3个月内 8 位分析师对 Reviva Pharmaceuticals Holdings, Inc. 的评级
EPS 预测 — RVPH
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.90
vs Est –$19.71
▲ 2,090.5% off
2025
Actual –$5.48
vs Est –$6.34
▲ 15.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — RVPH
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
